-
Key Brands
-
Statistics
-
Revenue
-
Contribution
-
Market data
| Coloxyl | Dexamfetamine | Gastro-Stop | Maltofer | Marcaine Adrenaline | Xylocaine |
|---|---|---|---|---|---|
| Emollient | Psychostimulants for ADHD | Anti-diarrhoeal | Iron supplement | Regional anaesthetic | Regional anaesthetic |
0
Products
Launched
Launched
(2024: 10)
0
Product
Recalls
Recalls
(2024: Nil)
0
%
Average Staff
Turnover
Turnover
(2024: 14%)
0
Work-related
Fatalities
Fatalities
(2024: Nil)
0
Sales
Representatives
Representatives
(2024: 88)
400
Permanent
Employees
Employees
June 2025
400
Permanent
Employees
Employees
June 2024
0
Products
Launched
Launched
(2022: 8)
Product
Recalls
Recalls
(2022: Nil)
0
%
Average Staff
Turnover
Turnover
(2022: 12%)
Work-related
Facilities
Facilities
(2022: Nil)
30
Sales
Representatives
Representatives
(2022: 83)
200
Permanent
Employees
Employees
(June 2022: 563)
| Revenue | 2025 R'million |
2024 (CER) R'million |
Change % |
|---|---|---|---|
| Commercial Pharmaceuticals | 5 748 | 5 651 | 2 |
| Over the counter | 2 448 | 2 327 | 5 |
| Prescription | 2 377 | 2 506 | (5) |
| Injectables | 923 | 818 | 13 |
| Manufacturing | |||
| Finished dose form | 563 | 749 | (25) |
| Total | 6 311 | 6 400 | (1) |
Note: Commercial Pharmaceuticals' revenue is by customer geography and Manufacturing revenue is by place of manufacture.
CER: Constant Exchange Rate
CER: Constant Exchange Rate
Contribution to Group revenue (%)
2025
Rest of Group
85
Australasia
15
Revenue by segment (%)
2025
Over the counter
39
Prescription
38
Injectables
14
Finished dose form
9
- Aspen ranks among the top five OTC companies in Australia by both value and volume*.
- Aspen continues to undergo recalibration with a focus on expanding the OTC segment reducing exposure to the Pharmaceutical Benefits Scheme.
- Aspen Australia has a diverse range of manufacturing capabilities covering liquids, creams, ointments, suspensions, tablets, capsules, and powders.
Source: IQVIA Combined National Sales Audit, June 2025.
